Characterization of Spontaneous and Precipitated Nicotine Withdrawal in the Mouse

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 2, 2003, Pages 526-534

  Damaj, M I ^a   Kao, W ^a   Martin, B R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT;

ABSTINENCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; HYPERALGESIA; MALE; MAZE TEST; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; TAIL FLICK TEST; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; MECAMYLAMINE; MICE; MICE, INBRED ICR; NICOTINE; NICOTINIC ANTAGONISTS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TOBACCO USE DISORDER;

EID: 0142210241     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.054908     Document Type: Article

References (23)

1. Aceto MD, Martin BR, Uwaydah IM, May EL, Harris LS, Izazola-Conde C, Dewey WL, and Vincek WC (1979) Optically pure (+)-nicotine from (±)-nicotine and biological comparisons with (-)-nicotine. J Med Chem 22:174-177.
2. Acheson RM, Ferris MJ, and Sinclair NM (1980) Transformations involving the pyrrolidine ring of nicotine. J Chem Soc 2:579-585.
3. Acri J (1994) Nicotine modulates effects of stress on acoustic startle reflexes in rats: dependence on dose, stressor and initial reactivity. Psychopharmacology (Berl) 116:255-265.
4. 2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacology 39:2770-2778.
5. Bencherif M, Lovette ME, Fowler KW, Arrington S, Reeves L, Caldwell WS, and Lippiello PM (1996) RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization. J Pharmacol Exp Ther 279:1413-1421.
6. Benowitz NL (1992) Cigarette smoking and nicotine addiction. Med Clin North Am 76:415-437.
7. Carroll ME, Lac ST, Asencio M, and Keenan RM (1989) Nicotine dependence in rats. Life Sci 45:1381-1388.
8. Corrigall WA, Herling S, and Coen KM (1989) Evidence for a behavioral deficit during withdrawal from chronic nicotine treatment. Pharmacol Biochem Behav 33:559-562.
9. Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, and Tyers MB (1990) Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 36:97-104.
10. Epping-Jordan MP, Watkins SS, Koob GF, and Markou A (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature (Lond) 393:76-79.
11. Helton D, Modlin D, Tizzano J, and Rasmussen K (1993) Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity and sensorimotor reactivity. Psychopharmacology (Berl) 113:205-210.
12. Hildebrand BE, Nomikos GG, Bondjers C, Nisell M, and Svensson TH (1997) Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology (Berl) 129:348-356.
13. Isola R, Vogelsberg V, Wemlinger TA, Neff NH, and Hadjiconstantinou M (1999) Nicotine abstinence in the mouse. Brain Res 850:189-196.
14. Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA, Cunningham JS, and Wilson OB (1992) Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779-784.
15. Marks MJ, Campbell SM, Romm E, and Collins AC (1991) Genotype influences the development of tolerance to nicotine in the mouse. J Pharmacol Exp Ther 259:392-402.
16. Marubio LM, Arroyo-Jimenez MM, Cordero-Erausquin M, Léna C, LeNovère N, de Kerchove d'Exaerde A, Huchet M, Damaj MI, and Changeux J-P (1999) Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature (Lond) 398:805-810.
17. McNeill AD, West RJ, Jarvis M, Jackson P, and Bryant A (1986) Cigarette withdrawal symptoms in adolescent smokers. Psychopharmacology (Berl) 90:533-536.
18. Nomikos GG, Hildebrand BE, Panagis G, and Svensson TH (1999) Nicotine withdrawal in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area. Neuroreport 10:697-702.
19. Papke RL, Sanberg PR, and Shytle RD (2001) Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther 297:646-656.
20. Piasecki TM, Niaura R, Shadel WG, Abrams A, Goldstein MG, Fiore MC, and Baker CM (2000) Smoking withdrawal dynamics in unaided smokers. J Abnorm Psychol 109:74-86.
21. Stolerman IP, Fink R, and Jarvik ME (1973) Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 29:329-342.
22. Suzuki T, Ise Y, Tsuda M, Maeda J, and Misawa M (1996) Mecamlyamine-precipitated nicotine-withdrawal aversion in rats. Eur J Pharmacol 314:281-284.
23. Watkins SS, Stinus L, Koob GF, and Markou A (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053-1064.